Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections
Gonorrhea is a reproductive complications in women and can facilitate human immunodeficiency virus (HIV) transmission. Effective treatment is a cornerstone of US gonorrhea control efforts, but treatment of gonorrhea has been complicated by the ability of Neisseria gonorrhoeae to develop anti-microbi...
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association 2012-11, Vol.308 (18), p.1850-1853 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1853 |
|---|---|
| container_issue | 18 |
| container_start_page | 1850 |
| container_title | JAMA : the journal of the American Medical Association |
| container_volume | 308 |
| creator | del Rio, Carlos Hall, Geraldine Holmes, King Soge, Olusegun Hook, Edward W Kirkcaldy, Robert D Workowski, Kimberly A Kidd, Sarah Weinstock, Hillard S Papp, John R Trees, David Peterman, Thomas A Bolan, Gail |
| description | Gonorrhea is a reproductive complications in women and can facilitate human immunodeficiency virus (HIV) transmission. Effective treatment is a cornerstone of US gonorrhea control efforts, but treatment of gonorrhea has been complicated by the ability of Neisseria gonorrhoeae to develop anti-microbial resistance. This report, using data from CDC's Gonococcal Isolate Surveillance Project (GISP), describes laboratory evidence of declining cefixime susceptibility among urethral N. gonorrhoeae isolates collected in the United States during 2006-11 and updates CDC's current recommendations for treatment of gonorrhea. CDC no longer recommends cefixime at any dose as a first-line regimen for treatment of gonococcal infections. If cefixime is used as an alternative agent, then the patient should return in 1 week for a test-of-cure at the site of infection. |
| doi_str_mv | 10.1001/2012.jama.11292 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1240660281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1391928</ama_id><sourcerecordid>2845980521</sourcerecordid><originalsourceid>FETCH-LOGICAL-a259t-db5362698d81be0d35faa366d712928c2673af563b5c41c1d7215adcabc316173</originalsourceid><addsrcrecordid>eNpFUU2LFDEQDaLguHoWPAW82rOpZDrd7U16dVwYXNiPc1OTVGsP3UmbZMC97d8Q_52_xLQjbl0KHu-jqMfYaxBrEALOpQC5PuCEawDZyCdsBaWqC1U29VO2EqKpi2pTb56zFzEeRB5Q1Yr9upstJuLJ8_ai_f3wM_Ib-nHEcbzntwFdnIaUyPKLIRJGihkkTBO5xLfHwdI4OIrveA4X7_lVwJG3NH_D0cfZh8FF_sXznXdfKXDk12T8lLU2Gz769D7wrXfeeGOy_tL1ZNLgXXzJnvU4Rnr1b5-xu08fb9vPxe5qe9l-2BUoyyYVdl8qLXVT2xr2JKwqe0Slta2WP9RG6kphX2q1L80GDNhKQonW4N4o0FCpM_b25DsH__1IMXUHfwwuR3YgN0JrIWvIrPMTywQfY6C-m8MwYbjvQHRLA93SQLc00P1tICvenBQL9J-sGshXqT_TwIQH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1240660281</pqid></control><display><type>article</type><title>Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections</title><source>American Medical Association Journals</source><creator>del Rio, Carlos ; Hall, Geraldine ; Holmes, King ; Soge, Olusegun ; Hook, Edward W ; Kirkcaldy, Robert D ; Workowski, Kimberly A ; Kidd, Sarah ; Weinstock, Hillard S ; Papp, John R ; Trees, David ; Peterman, Thomas A ; Bolan, Gail</creator><creatorcontrib>del Rio, Carlos ; Hall, Geraldine ; Holmes, King ; Soge, Olusegun ; Hook, Edward W ; Kirkcaldy, Robert D ; Workowski, Kimberly A ; Kidd, Sarah ; Weinstock, Hillard S ; Papp, John R ; Trees, David ; Peterman, Thomas A ; Bolan, Gail</creatorcontrib><description>Gonorrhea is a reproductive complications in women and can facilitate human immunodeficiency virus (HIV) transmission. Effective treatment is a cornerstone of US gonorrhea control efforts, but treatment of gonorrhea has been complicated by the ability of Neisseria gonorrhoeae to develop anti-microbial resistance. This report, using data from CDC's Gonococcal Isolate Surveillance Project (GISP), describes laboratory evidence of declining cefixime susceptibility among urethral N. gonorrhoeae isolates collected in the United States during 2006-11 and updates CDC's current recommendations for treatment of gonorrhea. CDC no longer recommends cefixime at any dose as a first-line regimen for treatment of gonococcal infections. If cefixime is used as an alternative agent, then the patient should return in 1 week for a test-of-cure at the site of infection.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/2012.jama.11292</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>Chicago: American Medical Association</publisher><subject>Drug resistance ; Drug therapy ; Evidence-based medicine ; Gonorrhea ; Medical treatment</subject><ispartof>JAMA : the journal of the American Medical Association, 2012-11, Vol.308 (18), p.1850-1853</ispartof><rights>Copyright American Medical Association Nov 14, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a259t-db5362698d81be0d35faa366d712928c2673af563b5c41c1d7215adcabc316173</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/2012.jama.11292$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/2012.jama.11292$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,776,780,3327,27901,27902,76231,76234</link.rule.ids></links><search><creatorcontrib>del Rio, Carlos</creatorcontrib><creatorcontrib>Hall, Geraldine</creatorcontrib><creatorcontrib>Holmes, King</creatorcontrib><creatorcontrib>Soge, Olusegun</creatorcontrib><creatorcontrib>Hook, Edward W</creatorcontrib><creatorcontrib>Kirkcaldy, Robert D</creatorcontrib><creatorcontrib>Workowski, Kimberly A</creatorcontrib><creatorcontrib>Kidd, Sarah</creatorcontrib><creatorcontrib>Weinstock, Hillard S</creatorcontrib><creatorcontrib>Papp, John R</creatorcontrib><creatorcontrib>Trees, David</creatorcontrib><creatorcontrib>Peterman, Thomas A</creatorcontrib><creatorcontrib>Bolan, Gail</creatorcontrib><title>Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections</title><title>JAMA : the journal of the American Medical Association</title><description>Gonorrhea is a reproductive complications in women and can facilitate human immunodeficiency virus (HIV) transmission. Effective treatment is a cornerstone of US gonorrhea control efforts, but treatment of gonorrhea has been complicated by the ability of Neisseria gonorrhoeae to develop anti-microbial resistance. This report, using data from CDC's Gonococcal Isolate Surveillance Project (GISP), describes laboratory evidence of declining cefixime susceptibility among urethral N. gonorrhoeae isolates collected in the United States during 2006-11 and updates CDC's current recommendations for treatment of gonorrhea. CDC no longer recommends cefixime at any dose as a first-line regimen for treatment of gonococcal infections. If cefixime is used as an alternative agent, then the patient should return in 1 week for a test-of-cure at the site of infection.</description><subject>Drug resistance</subject><subject>Drug therapy</subject><subject>Evidence-based medicine</subject><subject>Gonorrhea</subject><subject>Medical treatment</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpFUU2LFDEQDaLguHoWPAW82rOpZDrd7U16dVwYXNiPc1OTVGsP3UmbZMC97d8Q_52_xLQjbl0KHu-jqMfYaxBrEALOpQC5PuCEawDZyCdsBaWqC1U29VO2EqKpi2pTb56zFzEeRB5Q1Yr9upstJuLJ8_ai_f3wM_Ib-nHEcbzntwFdnIaUyPKLIRJGihkkTBO5xLfHwdI4OIrveA4X7_lVwJG3NH_D0cfZh8FF_sXznXdfKXDk12T8lLU2Gz769D7wrXfeeGOy_tL1ZNLgXXzJnvU4Rnr1b5-xu08fb9vPxe5qe9l-2BUoyyYVdl8qLXVT2xr2JKwqe0Slta2WP9RG6kphX2q1L80GDNhKQonW4N4o0FCpM_b25DsH__1IMXUHfwwuR3YgN0JrIWvIrPMTywQfY6C-m8MwYbjvQHRLA93SQLc00P1tICvenBQL9J-sGshXqT_TwIQH</recordid><startdate>20121114</startdate><enddate>20121114</enddate><creator>del Rio, Carlos</creator><creator>Hall, Geraldine</creator><creator>Holmes, King</creator><creator>Soge, Olusegun</creator><creator>Hook, Edward W</creator><creator>Kirkcaldy, Robert D</creator><creator>Workowski, Kimberly A</creator><creator>Kidd, Sarah</creator><creator>Weinstock, Hillard S</creator><creator>Papp, John R</creator><creator>Trees, David</creator><creator>Peterman, Thomas A</creator><creator>Bolan, Gail</creator><general>American Medical Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20121114</creationdate><title>Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections</title><author>del Rio, Carlos ; Hall, Geraldine ; Holmes, King ; Soge, Olusegun ; Hook, Edward W ; Kirkcaldy, Robert D ; Workowski, Kimberly A ; Kidd, Sarah ; Weinstock, Hillard S ; Papp, John R ; Trees, David ; Peterman, Thomas A ; Bolan, Gail</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a259t-db5362698d81be0d35faa366d712928c2673af563b5c41c1d7215adcabc316173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Drug resistance</topic><topic>Drug therapy</topic><topic>Evidence-based medicine</topic><topic>Gonorrhea</topic><topic>Medical treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>del Rio, Carlos</creatorcontrib><creatorcontrib>Hall, Geraldine</creatorcontrib><creatorcontrib>Holmes, King</creatorcontrib><creatorcontrib>Soge, Olusegun</creatorcontrib><creatorcontrib>Hook, Edward W</creatorcontrib><creatorcontrib>Kirkcaldy, Robert D</creatorcontrib><creatorcontrib>Workowski, Kimberly A</creatorcontrib><creatorcontrib>Kidd, Sarah</creatorcontrib><creatorcontrib>Weinstock, Hillard S</creatorcontrib><creatorcontrib>Papp, John R</creatorcontrib><creatorcontrib>Trees, David</creatorcontrib><creatorcontrib>Peterman, Thomas A</creatorcontrib><creatorcontrib>Bolan, Gail</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>del Rio, Carlos</au><au>Hall, Geraldine</au><au>Holmes, King</au><au>Soge, Olusegun</au><au>Hook, Edward W</au><au>Kirkcaldy, Robert D</au><au>Workowski, Kimberly A</au><au>Kidd, Sarah</au><au>Weinstock, Hillard S</au><au>Papp, John R</au><au>Trees, David</au><au>Peterman, Thomas A</au><au>Bolan, Gail</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><date>2012-11-14</date><risdate>2012</risdate><volume>308</volume><issue>18</issue><spage>1850</spage><epage>1853</epage><pages>1850-1853</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>Gonorrhea is a reproductive complications in women and can facilitate human immunodeficiency virus (HIV) transmission. Effective treatment is a cornerstone of US gonorrhea control efforts, but treatment of gonorrhea has been complicated by the ability of Neisseria gonorrhoeae to develop anti-microbial resistance. This report, using data from CDC's Gonococcal Isolate Surveillance Project (GISP), describes laboratory evidence of declining cefixime susceptibility among urethral N. gonorrhoeae isolates collected in the United States during 2006-11 and updates CDC's current recommendations for treatment of gonorrhea. CDC no longer recommends cefixime at any dose as a first-line regimen for treatment of gonococcal infections. If cefixime is used as an alternative agent, then the patient should return in 1 week for a test-of-cure at the site of infection.</abstract><cop>Chicago</cop><pub>American Medical Association</pub><doi>10.1001/2012.jama.11292</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0098-7484 |
| ispartof | JAMA : the journal of the American Medical Association, 2012-11, Vol.308 (18), p.1850-1853 |
| issn | 0098-7484 1538-3598 |
| language | eng |
| recordid | cdi_proquest_journals_1240660281 |
| source | American Medical Association Journals |
| subjects | Drug resistance Drug therapy Evidence-based medicine Gonorrhea Medical treatment |
| title | Update to CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A02%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Update%20to%20CDC%E2%80%99s%20Sexually%20Transmitted%20Diseases%20Treatment%20Guidelines,%202010:%20Oral%20Cephalosporins%20No%20Longer%20a%20Recommended%20Treatment%20for%20Gonococcal%20Infections&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=del%20Rio,%20Carlos&rft.date=2012-11-14&rft.volume=308&rft.issue=18&rft.spage=1850&rft.epage=1853&rft.pages=1850-1853&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/2012.jama.11292&rft_dat=%3Cproquest_cross%3E2845980521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1240660281&rft_id=info:pmid/&rft_ama_id=1391928&rfr_iscdi=true |